Strides dips 6% from high on profit booking as Aditya Puri joins as advisor

Shares of Strides Pharma fell 3 per cent to Rs 939, down 6 per cent from its early morning high on the BSE on Friday after Aditya Puri joined as advisor to the Strides Group & Director of Stelis Biopharma. The drug maker's stock hit a 52-week high of Rs 1,000 in intra-day trade today.

In the past six months, the stock has zoomed 130 per cent, as compared to 33 per cent rally in the S&P BSE Sensex.

At 10:27 am, the stock was trading 3.3 per cent lower at Rs 941 on the BSE, against, 0.86